BenQ Medical's board of directors approved on 4 August that in order to strengthen the competitiveness of the medical device business and expand product lines in dialysis, medical aesthetics, and other fields, BenQ Medical will acquire 40% of the shares of K2 International Medical Inc. for NT$400 million, which is expected to be completed in September. BenQ Medical will become the fleet of Qisda/BenQ Group in terms of medical products, expanding its product portfolio and overseas distributions, laying the groundwork for the next stage of growth and accelerating the expansion of business opportunities in the Asian medical devices market.
BenQ Medical's Vice Chairman, Mr. Harry Yang, said that BenQ Medical spans three major areas, namely medical services, medical equipment, and medical consumables, and provides high-quality products and services to medical institutions and end-consumers. Through the integration of K2, BenQ Medical will strengthen its competitiveness, accelerate the growth momentum of the Group's medical devices-related companies, and highlight the value of the Group's business.
President of BenQ Medical, Mr. Michael Guan, pointed out that through the merger of K-2 Medical, the Group can further expand its haemodialysis and plasma therapy related consumables and distribution channels, which will not only increase the Group's product line, but also further extend its channels to carry out closer integration in the ASEAN and Asian markets such as mainland China, and to expand its service capacity in order to satisfy the needs of its domestic and overseas customers.
K2 is one of the top 5 haemodialysis and medical aesthetics equipment distributors in Taiwan. In 2018, it joined the BenQ/Qisda, and in addition to steadily expanding its market in Taiwan, it has set up subsidiaries in Shanghai and Thailand, and in 2020, it invested in Frismed, the largest distributor of blood donor consumables in Indonesia, so it is actively laying out its footprints in Asia. In 2022, the company reported a consolidated revenue of NT$1.43 billion and a net income of NT$5.6 per share after tax.
BenQ Medical is one of the top 3 surgical equipment suppliers in Mainland China and the first brand imported to India. It is the first medical device company of BenQ/Qisda Group, and has acquired 7 enterprises over the past 13 years since joining the company in 2010, spanning over hospital consumables, medical imaging equipment, and hearing aids business, etc. After investing in Concord Medical to enter into the field of medical management in 2022, the revenue and profit have all leapt significantly, and the company will also be selected as a member of World Magazine's "Fastest Growing Company" in 2023. In 2023, the company was also selected as one of the "Top 100 Fastest Growing Companies" by the "CommonWealth Magazine" in Taiwan.
